During the last session, Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s traded shares were 0.37 million, with the beta value of the company hitting 0.43. At the end of the trading day, the stock’s price was $1.07, reflecting an intraday gain of 20.22% or $0.18. The 52-week high for the TLSA share is $1.91, that puts it down -78.5 from that peak though still a striking 54.21% gain since the share price plummeted to a 52-week low of $0.49. The company’s market capitalization is $118.41M, and the average intraday trading volume over the past 10 days was 0.31 million shares, and the average trade volume was 957.82K shares over the past three months.
Tiziana Life Sciences Ltd (TLSA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. TLSA has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) trade information
Tiziana Life Sciences Ltd (TLSA) registered a 20.22% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 20.22% in intraday trading to $1.07, hitting a weekly high. The stock’s 5-day price performance is 37.18%, and it has moved by -22.74% in 30 days. Based on these gigs, the overall price performance for the year is 94.37%. The short interest in Tiziana Life Sciences Ltd (NASDAQ:TLSA) is 0.75 million shares and it means that shorts have 0.71 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -12.98%.
TLSA Dividends
Tiziana Life Sciences Ltd is due to release its next quarterly earnings on 2020-Sep-29. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s Major holders
Tiziana Life Sciences Ltd insiders own 35.56% of total outstanding shares while institutional holders control 0.89%, with the float percentage being 1.39%. ALPHAMARK ADVISORS, LLC is the largest shareholder of the company, while 34.0 institutions own stock in it. As of 2024-06-30, the company held over 4589.0 shares (or 0.0045% of all shares), a total value of $0.31 million in shares.
